Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

1.

A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia.

Cell.
Gröschel S, Sanders MA, Hoogenboezem R, de Wit E, Bouwman BA, Erpelinck C, van der Velden VH, Havermans M, Avellino R, van Lom K, Rombouts EJ, van Duin M, Döhner K, Beverloo HB, Bradner JE, Döhner H, Löwenberg B, Valk PJ, Bindels EM, de Laat W, Delwel R.
| Apr 10, 2014
2.

Differential regulation of myeloid leukemias by the bone marrow microenvironment.

Nat. Med.
Krause DS, Fulzele K, Catic A, Sun CC, Dombkowski D, Hurley MP, Lezeau S, Attar E, Wu JY, Lin HY, Divieti-Pajevic P, Hasserjian RP, Schipani E, Van Etten RA, Scadden DT.
| 10 27, 2013
3.

Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML.

Cell.
Vo TT, Ryan J, Carrasco R, Neuberg D, Rossi DJ, Stone RM, Deangelo DJ, Frattini MG, Letai A.
| Oct 12, 2012
4.

Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells.

Proc. Natl. Acad. Sci. U.S.A.
Maclean GA, Menne TF, Guo G, Sanchez DJ, Park IH, Daley GQ, Orkin SH.
| Oct 23, 2012
5.

Spectrum of somatic mitochondrial mutations in five cancers.

Proc. Natl. Acad. Sci. U.S.A.
Larman TC, DePalma SR, Hadjipanayis AG, Protopopov A, Zhang J, Gabriel SB, Chin L, Seidman CE, Kucherlapati R, Seidman JG.
| Aug 28, 2012
6.

Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia.

Nat. Med.
Kentsis A, Reed C, Rice KL, Sanda T, Rodig SJ, Tholouli E, Christie A, Valk PJ, Delwel R, Ngo V, Kutok JL, Dahlberg SE, Moreau LA, Byers RJ, Christensen JG, Vande Woude G, Licht JD, Kung AL, Staudt LM, Look AT.
| 3 30, 2011
7.

The secrets of the bone marrow niche: Metabolic priming for AML.

Nat. Med.
Yusuf RZ, Wang YH, Scadden DT.
| 06 06, 2012
8.

Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy.

Science.
Ni Chonghaile T, Sarosiek KA, Vo TT, Ryan JA, Tammareddi A, Moore Vdel G, Deng J, Anderson KC, Richardson P, Tai YT, Mitsiades CS, Matulonis UA, Drapkin R, Stone R, Deangelo DJ, McConkey DJ, Sallan SE, Silverman L, Hirsch MS, Carrasco DR, Letai A.
| Nov 25, 2011
9.

AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias.

Cell.
Sykes SM, Lane SW, Bullinger L, Kalaitzidis D, Yusuf R, Saez B, Ferraro F, Mercier F, Singh H, Brumme KM, Acharya SS, Scholl C, Schöll C, Tothova Z, Attar EC, Fröhling S, DePinho RA, Armstrong SA, Gilliland DG, Scadden DT.
| Sep 2, 2011
10.

Clinical effect of point mutations in myelodysplastic syndromes.

N. Engl. J. Med.
Bejar R, Stevenson K, Abdel-Wahab O, Galili N, Nilsson B, Garcia-Manero G, Kantarjian H, Raza A, Levine RL, Neuberg D, Ebert BL.
| Jun 30, 2011
11.

SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction.

Nature.
Inuzuka H, Shaik S, Onoyama I, Gao D, Tseng A, Maser RS, Zhai B, Wan L, Gutierrez A, Lau AW, Xiao Y, Christie AL, Aster J, Settleman J, Gygi SP, Kung AL, Look T, Nakayama KI, DePinho RA, Wei W.
| Mar 3, 2011
13.

Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2.

Nature.
Ko M, Huang Y, Jankowska AM, Pape UJ, Tahiliani M, Bandukwala HS, An J, Lamperti ED, Koh KP, Ganetzky R, Liu XS, Aravind L, Agarwal S, Maciejewski JP, Rao A.
| Dec 9, 2010
14.

T-cell receptor-driven lymphomagenesis in mice derived from a reprogrammed T cell.

Proc. Natl. Acad. Sci. U.S.A.
Serwold T, Hochedlinger K, Swindle J, Hedgpeth J, Jaenisch R, Weissman IL.
| Nov 2, 2010
16.

Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia.

Nat. Med.
Kharas MG, Lengner CJ, Al-Shahrour F, Bullinger L, Ball B, Zaidi S, Morgan K, Tam W, Paktinat M, Okabe R, Gozo M, Einhorn W, Lane SW, Scholl C, Fröhling S, Fleming M, Ebert BL, Gilliland DG, Jaenisch R, Daley GQ.
| 07 08, 2010
17.

The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML.

Science.
Wang Y, Krivtsov AV, Sinha AU, North TE, Goessling W, Feng Z, Zon LI, Armstrong SA.
| Mar 26, 2010
18.

Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia.

Nature.
Raaijmakers MH, Mukherjee S, Guo S, Zhang S, Kobayashi T, Schoonmaker JA, Ebert BL, Al-Shahrour F, Hasserjian RP, Scadden EO, Aung Z, Matza M, Merkenschlager M, Lin C, Rommens JM, Scadden DT.
| Apr 8, 2010
19.

Abcb10 physically interacts with mitoferrin-1 (Slc25a37) to enhance its stability and function in the erythroid mitochondria.

Proc. Natl. Acad. Sci. U.S.A.
Chen W, Paradkar PN, Li L, Pierce EL, Langer NB, Takahashi-Makise N, Hyde BB, Shirihai OS, Ward DM, Kaplan J, Paw BH.
| Sep 22, 2009